FDA advisers vote to replace original COVID vaccine with bivalent boosters despite lack of clinical trial data -- Health & Wellness -- Sott.net
Advisers to the U.S. Food and Drug Administration (FDA) on Thursday voted unanimously to replace the original Pfizer and Moderna primary series mRNA COVID-19 vaccines with the bivalent boosters designed to target Omicron variants. The bivalent...
Source: sott.net